Corbenic Partners’s Immunogen Inc IMGN Stock Holding History

Corbenic Partners’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-240	Closed	-$1K	–	219
2016 Q3	$1K	Buy	+240	New	+$698	﹤0.01%	199

Other funds holding IMGN

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Corbenic Partners's IMGN Position: Q4 2016 in Review

Corbenic Partners sold out of Immunogen Inc (IMGN) in Q4 2016, closing a stake of 240 shares — an estimated $1K sold.

Corbenic Partners first reported a position in IMGN in Q3 2016 and held it in 1 quarter. The position peaked at $1K in Q3 2016. 156 funds tracked by Wall St. Rank hold IMGN as of Q4 2016.

Corbenic Partners reported no remaining Immunogen Inc position as of Q4 2016 after selling out during the quarter.
Corbenic Partners sold 240 Immunogen Inc shares in Q4 2016, an estimated $1K.
Corbenic Partners first reported a position in Immunogen Inc in Q3 2016 and held it in 1 quarter.
Corbenic Partners's Immunogen Inc position peaked at $1K in Q3 2016.
156 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2016.

Based on Corbenic Partners's 13F filing for Q4 2016, filed 6 Feb 2017.